These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 38884554

  • 1. Multicentric Longitudinal Prospective Study in a European Cohort of MYO7A Patients: Disease Course and Implications for Gene Therapy.
    Testa F, Carreño E, van den Born LI, Melillo P, Perea-Romero I, Di Iorio V, Risca G, Iodice CM, Pennings RJE, Karali M, Banfi S, Auricchio A, Galimberti S, Ayuso C, Simonelli F.
    Invest Ophthalmol Vis Sci; 2024 Jun 03; 65(6):25. PubMed ID: 38884554
    [Abstract] [Full Text] [Related]

  • 2. Biomarkers in Usher syndrome: ultra-widefield fundus autofluorescence and optical coherence tomography findings and their correlation with visual acuity and electrophysiology findings.
    Mustafic N, Ristoldo F, Nguyen V, Fraser CL, Invernizzi A, Jamieson RV, Grigg JR.
    Doc Ophthalmol; 2020 Dec 03; 141(3):205-215. PubMed ID: 32240425
    [Abstract] [Full Text] [Related]

  • 3. Natural history and retinal structure in patients with Usher syndrome type 1 owing to MYO7A mutation.
    Lenassi E, Saihan Z, Cipriani V, Le Quesne Stabej P, Moore AT, Luxon LM, Bitner-Glindzicz M, Webster AR.
    Ophthalmology; 2014 Feb 03; 121(2):580-7. PubMed ID: 24199935
    [Abstract] [Full Text] [Related]

  • 4. PHENOTYPIC CHARACTERISTICS OF ROD-CONE DYSTROPHY ASSOCIATED WITH MYO7A MUTATIONS IN A LARGE FRENCH COHORT.
    Khateb S, Mohand-Saïd S, Nassisi M, Bonnet C, Roux AF, Andrieu C, Antonio A, Condroyer C, Zeitz C, Devisme C, Loundon N, Marlin S, Petit C, Bodaghi B, Sahel JA, Audo I.
    Retina; 2020 Aug 03; 40(8):1603-1615. PubMed ID: 31479088
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. CLINICAL PRESENTATION AND DISEASE COURSE OF USHER SYNDROME BECAUSE OF MUTATIONS IN MYO7A OR USH2A.
    Testa F, Melillo P, Bonnet C, Marcelli V, de Benedictis A, Colucci R, Gallo B, Kurtenbach A, Rossi S, Marciano E, Auricchio A, Petit C, Zrenner E, Simonelli F.
    Retina; 2017 Aug 03; 37(8):1581-1590. PubMed ID: 27828912
    [Abstract] [Full Text] [Related]

  • 9. Optical coherence tomography biomarkers in MYO7A-inherited retinal dystrophy: longitudinal study in pediatric patients.
    Subirà O, Català-Mora J, Del Prado C, Díaz-Cascajosa J, Barraso Rodrigo M, Cobos E, Aguilera C, Esteve-Garcia A, García-Arumí J, Caminal JM.
    Graefes Arch Clin Exp Ophthalmol; 2024 Oct 03; 262(10):3375-3384. PubMed ID: 38871877
    [Abstract] [Full Text] [Related]

  • 10. Fundus autofluorescence and optical coherence tomography in relation to visual function in Usher syndrome type 1 and 2.
    Fakin A, Jarc-Vidmar M, Glavač D, Bonnet C, Petit C, Hawlina M.
    Vision Res; 2012 Dec 15; 75():60-70. PubMed ID: 23000274
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Genetics, Clinical Characteristics, and Natural History of PDE6B-Associated Retinal Dystrophy.
    Hashem SA, Georgiou M, Fujinami-Yokokawa Y, Laich Y, Daich Varela M, de Guimaraes TAC, Ali N, Mahroo OA, Webster AR, Fujinami K, Michaelides M.
    Am J Ophthalmol; 2024 Jul 15; 263():1-10. PubMed ID: 38364953
    [Abstract] [Full Text] [Related]

  • 13. Genotype-phenotype correlation in patients with Usher syndrome and pathogenic variants in MYO7A: implications for future clinical trials.
    Galbis-Martínez L, Blanco-Kelly F, García-García G, Ávila-Fernández A, Jaijo T, Fuster-García C, Perea-Romero I, Zurita-Muñoz O, Jimenez-Rolando B, Carreño E, García-Sandoval B, Millán JM, Ayuso C.
    Acta Ophthalmol; 2021 Dec 15; 99(8):922-930. PubMed ID: 33576163
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Characterisation of microvascular abnormalities using OCT angiography in patients with biallelic variants in USH2A and MYO7A.
    Hagag AM, Mitsios A, Gill JS, Nunez Do Rio JM, Theofylaktopoulos V, Houston S, Webster AR, Dubis AM, Moosajee M.
    Br J Ophthalmol; 2020 Apr 15; 104(4):480-486. PubMed ID: 31266775
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The Natural History of the Progression of Atrophy Secondary to Stargardt Disease (ProgStar) Studies: Design and Baseline Characteristics: ProgStar Report No. 1.
    Strauss RW, Ho A, Muñoz B, Cideciyan AV, Sahel JA, Sunness JS, Birch DG, Bernstein PS, Michaelides M, Traboulsi EI, Zrenner E, Sadda S, Ervin AM, West S, Scholl HP, Progression of Stargardt Disease Study Group.
    Ophthalmology; 2016 Apr 15; 123(4):817-28. PubMed ID: 26786511
    [Abstract] [Full Text] [Related]

  • 18. LONGITUDINAL CHANGES IN EYES WITH HYDROXYCHLOROQUINE RETINAL TOXICITY.
    Allahdina AM, Chen KG, Alvarez JA, Wong WT, Chew EY, Cukras CA.
    Retina; 2019 Mar 15; 39(3):473-484. PubMed ID: 30741731
    [Abstract] [Full Text] [Related]

  • 19. Morpho-functional correlation of fundus autofluorescence in Stargardt disease.
    Parodi MB, Iacono P, Triolo G, La Spina C, Zucchiatti I, Cicinelli MV, Borrelli E, Manitto MP, Martina E, Bandello F.
    Br J Ophthalmol; 2015 Oct 15; 99(10):1354-9. PubMed ID: 25837607
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.